Cited by 461Antifungal resistance and susceptibilityFungal and yeast genetics researchFungal Plant Pathogen Control

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Resistance Mechanisms in Clinical Isolates of Candida albicans

Open access

White, Theodore C., Holleman, Scott, Dy, Francis, Mirels, Laurence F., Stevens, David A.·2002·Antimicrobial Agents and Chemotherapy

DOI 10.1128/aac.46.6.1704-1713.2002PMC PMC127245

Open this paper in CoChat — free account

Abstract

Resistance to azole antifungals continues to be a significant problem in the common fungal pathogen Candida albicans . Many of the molecular mechanisms of resistance have been defined with matched sets of susceptible and resistant clinical isolates from the same strain. Mechanisms that have been identified include alterations in the gene encoding the target enzyme ERG11 or overexpression of efflux pump genes including CDR1 , CDR2 , and MDR1 . In the present study, a collection of unmatched clinical isolates of C. albicans was analyzed for the known molecular mechanisms of resistance by standard methods. The collection was assembled so that approximately half of the isolates were resistant to azole drugs. Extensive cross-resistance was observed for fluconazole, clotrimazole, itraconazole, and ketoconazole. Northern blotting analyses indicated that overexpression of CDR1 and CDR2 correlates with resistance, suggesting that the two genes may be coregulated. MDR1 overexpression was observed infrequently in some resistant isolates. Overexpression of FLU1 , an efflux pump gene related to MDR1 , did not correlate with resistance, nor did overexpression of ERG11 . Limited analysis of the ERG11 gene sequence identified several point mutations in resistant isolates; these mutations have been described previously. Two of the most common point mutations in ERG11 associated with resistance, D116E and E266D, were tested by restriction fragment length polymorphism analysis of the isolates from this collection. The results indicated that the two mutations occur frequently in different isolates of C. albicans and are not reliably associated with resistance. These analyses emphasize the diversity of mechanisms that result in a phenotype of azole resistance. They suggest that the resistance mechanisms identified in matched sets of susceptible and resistant isolates are not sufficient to explain resistance in a collection of unmatched clinical isolates and that additional mechanisms have yet to be discovered.

Integrity signals

Registry

Crossref · 10.1128/aac.46.6.1704-1713.2002

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · PEDIATRICS · doi:10.1542/peds.65.1.187 · Cited by 14,736
A ten-minute DNA preparation from yeast efficiently releases autonomous plasmids for transformaion of Escherichia coli
Hoffman, C. S., & Winston, F. (1987) · Gene · doi:10.1016/0378-1119(87)90131-4 · Cited by 2,492
Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353
Self-citation
Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections
Rex, J. H., Pfaller, M. A., Galgiani, J. N., Bartlett, M. S., Espinel-Ingroff, A., Ghannoum, M. A., Lancaster, M., Odds, F. C., Rinaldi, M. G., Walsh, T. J., et al. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.2.235 · Cited by 855
Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters
Sanglard, D., Kuchler, K., Ischer, F., Pagani, J. L., Monod, M., & Bille, J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2378 · Cited by 815
Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus
White, T. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1482 · Cited by 612
Self-citation
Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene
Sanglard, D., Ischer, F., Monod, M., & Bille, J. (1997) · Microbiology · doi:10.1099/00221287-143-2-405 · Cited by 587
Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals
Prasad, R., De Wergifosse, P., Goffeau, A., & Balzi, E. (1995) · Current Genetics · doi:10.1007/bf00352101 · Cited by 486
Prevalence of Molecular Mechanisms of Resistance to Azole Antifungal Agents in Candida albicans Strains Displaying High-Level Fluconazole Resistance Isolated from Human Immunodeficiency Virus-Infected Patients
Perea, S., López-Ribot, J. L., Kirkpatrick, W. R., McAtee, R. K., Santillán, R. A., Martı́nez, M., Calabrese, D., Sanglard, D., & Patterson, T. F. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.10.2676-2684.2001 · Cited by 470

Show all 42 references

Research works printed but not linked: 2

Holmberg, K., and D. A. Stevens. 1999. Resistance to antifungal drugs: current status and clinical implications. Curr. Opin. Anti-Infective Investig. Drugs1:306-317.
Odds F. C. 1988. Candida and Candidosis: a review and bibliography. Bailliere Tindall London United Kingdom.

Sorted by citations

Items 101–200 of 461

Highly Potential Antifungal Activity of Quantum-Sized Silver Nanoparticles Against Candida albicans
Selvaraj, M., Pandurangan, P., Ramasami, N., Rajendran, S. B., Sangilimuthu, S. N., & Perumal, P. (2014) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-014-0782-9 · Cited by 75
Inactivation of Sterol Δ 5,6 -Desaturase Attenuates Virulence in Candida albicans
Chau, A. S., Gurnani, M., Hawkinson, R., Laverdière, M., Cacciapuoti, A. F., & McNicholas, P. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3646-3651.2005 · Cited by 75
Rapid, High-Throughput, Multiplex, Real-Time PCR for Identification of Mutations in the cyp51A Gene of Aspergillus fumigatus That Confer Resistance to Itraconazole
Balashov, S. V., Gardiner, R. E., Park, S., & Perlin, D. S. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.1.214-222.2005 · Cited by 73
Coping with Stress and the Emergence of Multidrug Resistance in Fungi
Shor, E., & Perlin, D. S. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004668 · Cited by 73
Multiple roles of ABC transporters in yeast
Kumari, S., Kumar, M., Gaur, N. A., & Prasad, R. (2021) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2021.103550 · Cited by 66
Isolation of peptides of the brevinin‐1 family with potent candidacidal activity from the skin secretions of the frog Rana boylii
Conlon, J. M., Sonnevend, Á., Patel, M., Davidson, C., Nielsen, P. F., Pál, T., & Smith, L. A. R. (2003) · Journal of Peptide Research · doi:10.1034/j.1399-3011.2003.00090.x · Cited by 70
Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance
Niimi, M., Niimi, K., Takano, Y., Holmes, A. R., Fischer, F. J., Uehara, Y., & Cannon, R. D. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh456 · Cited by 69
The synthesis and synergistic antifungal effects of chalcones against drug resistant Candida albicans
Wang, Y., Dong, H., Zhao, F., Jie, W., Yan, F., Jiang, Y., & Jin, Y. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.05.013 · Cited by 69
Synthesis, biological activity, DNA binding and anion sensors, molecular structure and quantum chemical studies of a novel bidentate Schiff base derived from 3,5-bis(triflouromethyl)aniline and salicylaldehyde
Yıldız, M., Karpuz, Ö., Zeyrek, C. T., Boyacıoğlu, B., Dal, H., Demir, N., YILDIRIM, N., & Ünver, H. (2015) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2015.03.047 · Cited by 67
Novel strategies to fightCandidaspecies infection
Rodrigues, M. E., Silva, S. M., Azeredo, J., & Henriques, M. (2014) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2014.974500 · Cited by 69
The Candida albicans Lanosterol 14-α-Demethylase ( ERG11 ) Gene Promoter Is Maximally Induced after Prolonged Growth with Antifungal Drugs
Song, J. L., Harry, J. B., Eastman, R. T., Oliver, B. G. G., & White, T. C. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1136-1144.2004 · Cited by 68
Self-citation
Persistent Candida albicans colonization and molecular mechanisms of azole resistance in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients
Siikala, E., Rautemaa, R., Richardson, M., Saxen, H., Bowyer, P., & Sanglard, D. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq354 · Cited by 66
Overexpression of CDR1 and CDR2 Genes Plays an Important Role in Fluconazole Resistance in Candida albicans with G487T and T916C Mutations
Chen, L., Yh, X., Zhou, C., Zhao, J., Li, C., & Wang, R. (2010) · Journal of International Medical Research · doi:10.1177/147323001003800216 · Cited by 66
Linking Cellular Morphogenesis with Antifungal Treatment and Susceptibility in Candida Pathogens
Sharma, J., Rosiana, S., Razzaq, I., & Shapiro, R. S. (2019) · Journal of Fungi · doi:10.3390/jof5010017 · Cited by 69
High-Resolution SNP/CGH Microarrays Reveal the Accumulation of Loss of Heterozygosity in Commonly UsedCandida albicansStrains
Abbey, D., Hickman, M. A., Gresham, D., & Berman, J. G. (2011) · G3 Genes Genomes Genetics · doi:10.1534/g3.111.000885 · Cited by 66
Toxicity and Antimicrobial Activity of a Hydrocolloid Dressing Containing Silver Particles in an ex vivo Model of Cutaneous Infection
Schaller, M., Laude, J., Bodewaldt, H., Hamm, G., & Korting, H. C. (2003) · Skin Pharmacology and Physiology · doi:10.1159/000074060 · Cited by 63
Reversal of Fluconazole Resistance by Sulfated Sterols from the Marine Sponge Topsentia sp.
DiGirolamo, J. A., Li, X., Jacob, M. R., Clark, A. M., & Ferreira, D. (2009) · Journal of Natural Products · doi:10.1021/np900177m · Cited by 63
A Candida albicans Petite Mutant Strain with Uncoupled Oxidative Phosphorylation Overexpresses MDR1 and Has Diminished Susceptibility to Fluconazole and Voriconazole
Cheng, S., Clancy, C. J., Nguyen, K. T., Clapp, W., & Nguyen, M. H. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00182-07 · Cited by 62
Novel Strategies to Combat the Emerging Drug Resistance in Human Pathogenic Microbes
Qadri, H., Shah, A. H., & Mir, M. A. (2020) · Current Drug Targets · doi:10.2174/1389450121666201228123212 · Cited by 64
Systemic Antifungal Therapy: New Options, New Challenges
Wong‐Beringer, A., & Kriengkauykiat, J. (2003) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.14.1441.31938 · Cited by 63
Molecular Diagnosis of Brettanomyces bruxellensis’ Sulfur Dioxide Sensitivity Through Genotype Specific Method
Avramova, M., Vallet-Courbin, A., Maupeu, J., Masneuf‐Pomarède, I., & Albertin, W. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01260 · Cited by 69
Rapid detection of ERG11 gene mutations in clinical Candida albicans isolates with reduced susceptibility to fluconazole by rolling circle amplification and DNA sequencing
Wang, H., Kong, F., Sorrell, T. C., Wang, B., McNicholas, P., Pantarat, N., Ellis, D., Xiao, M., Widmer, F., & Chen, S. C. (2009) · BMC Microbiology · doi:10.1186/1471-2180-9-167 · Cited by 58
Candida albicans Adhesion to and Invasion and Damage of Vaginal Epithelial Cells: Stage-Specific Inhibition by Clotrimazole and Bifonazole
Wächtler, B., Wilson, D., & Hube, B. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00144-11 · Cited by 59
Drug-Induced Regulation of the MDR1 Promoter in Candida albicans
Harry, J. B., Oliver, B. G., Song, J. L., Silver, P. M., Little, J. T., Choiniere, J., & White, T. C. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.2785-2792.2005 · Cited by 58
Self-citation
Influence of Culture Media on Biofilm Formation by Candida Species and Response of Sessile Cells to Antifungals and Oxidative Stress
Serrano‐Fujarte, I., López-Romero, E., Reyna-López, G. E., Martínez-Gámez, M. A., Vega‐González, A., & Cuéllar‐Cruz, M. (2015) · BioMed Research International · doi:10.1155/2015/783639 · Cited by 62
Genetic basis of antifungal drug resistance
Marie, C. S., & White, T. C. (2009) · Current Fungal Infection Reports · doi:10.1007/s12281-009-0021-y · Cited by 61
Self-citation
Inhibitors of the Candida albicans Major Facilitator Superfamily Transporter Mdr1p Responsible for Fluconazole Resistance
Keniya, M. V., Fleischer, E., Klinger, A., Cannon, R. D., & Monk, B. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126350 · Cited by 58
Multidrug transporters of Candida species in clinical azole resistance
Prasad, R., Nair, R., & Banerjee, A. (2019) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2019.103252 · Cited by 60
Biosynthesis, Characterization, and Antifungal Activity of the Silver Nanoparticles Against Pathogenic Candida species
Khatoon, N., Mishra, A., Alam, H., Manzoor, N., & Sardar, M. (2015) · BioNanoScience · doi:10.1007/s12668-015-0163-z · Cited by 56
Ibuprofen reverts antifungal resistance onCandida albicansshowing overexpression of CDR genes
Ricardo, E., Costa‐de‐Oliveira, S., Silva-Dias, A., Guerra, J., Rodrigues, A. G., & Pina‐Vaz, C. (2009) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2009.00504.x · Cited by 56
Relationship between antifungal resistance of fluconazole resistant Candida albicans and mutations in ERG 11 gene
Li-juan, F. E. N. G., Wan, Z., Wang, X., Li, R., & Liu, W. Y. (2010) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.2010.05.007 · Cited by 56
Mechanisms of azole resistance in Candida albicans clinical isolates from Shanghai, China
Liu, J.-Y., Shi, C., Wang, Y., Li, W.-J., Zhao, Y., & Xiang, M.-J. (2015) · Research in Microbiology · doi:10.1016/j.resmic.2015.02.009 · Cited by 54
Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A
Shinde, R. B., Chauhan, N. M., Raut, J. S., & Karuppayil, S. M. (2012) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-11-27 · Cited by 54
Fluconazole and itraconazole susceptibility ofclinical isolates of Cryptococcus neoformans at a tertiary care centre in India: a need for care
Datta, K. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg399 · Cited by 54
Regulation of azole drug susceptibility by Candida albicans protein kinase CK2
Bruno, V. M., & Mitchell, A. P. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04562.x · Cited by 55
Investigation of mutations in Erg11 gene of fluconazole resistant Candida albicans isolates from Turkish hospitals
Manastır, L., Ergon, M. C., & Yücesoy, M. (2009) · Mycoses · doi:10.1111/j.1439-0507.2009.01766.x · Cited by 53
Iron deprivation inducesEFG1-mediated hyphal development inCandida albicanswithout affecting biofilm formation
Hameed, S., Prasad, T., Banerjee, D., Chandra, A., Mukhopadhyay, C. K., Goswami, S. K., Lattif, A. A., Chandra, J., Mukherjee, P. K., Ghannoum, M. A., et al. (2008) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2008.00394.x · Cited by 52
Establishing Surrogate Markers for FluconazoleResistance in Candida albicans
Park, S., & Perlin, D. S. (2005) · Microbial Drug Resistance · doi:10.1089/mdr.2005.11.232 · Cited by 53
Caenorhabditis elegans as a Model Host to Monitor the Candida Infection Processes
Elkabti, A. B., Issi, L., & Rao, R. P. (2018) · Journal of Fungi · doi:10.3390/jof4040123 · Cited by 51
ROX1 and ERG Regulation in Saccharomyces cerevisiae : Implications for Antifungal Susceptibility
Henry, K. W., Nickels, J. T., & Edlind, T. D. (2002) · Eukaryotic Cell · doi:10.1128/ec.1.6.1041-1044.2002 · Cited by 51
Antifungal activity of a novel quercetin derivative bearing a trifluoromethyl group on Candida albicans
Tempesti, T. C., Alvarez, M. G., de Araújo, M. F., Júnior, F. E. A. C., de Carvalho, M. G., & Durantini, E. N. (2011) · Medicinal Chemistry Research · doi:10.1007/s00044-011-9750-x · Cited by 50
Influence of plant part, season of collection and content of the main active constituent, on the antifungal properties of Polygonum acuminatum Kunth.
Derita, M., Leiva-Mora, M., & Zacchino, S. A. (2009) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2009.05.029 · Cited by 50
Transcriptional response to fluconazole and amphotericin B in Candida albicans biofilms
Nailis, H., Vandenbosch, D., Deforce, D. L. D., Nelis, H. J. C. F., & Coenye, T. (2010) · Research in Microbiology · doi:10.1016/j.resmic.2010.02.004 · Cited by 49
NB-002, a Novel Nanoemulsion with Broad Antifungal Activity against Dermatophytes, Other Filamentous Fungi, and Candida albicans
Pannu, J., McCarthy, A. D., Martín, A. V., Hamouda, T., Ciotti, S., Fothergill, A. W., & Sutcliffe, J. A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00218-09 · Cited by 49
Up-regulation of ERG11 gene among fluconazole-resistant Candida albicans generated in vitro: is there any clinical implication?
Ribeiro, M. A., & Paula, C. R. (2006) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2006.04.019 · Cited by 49
Mechanism of Action of Tetrandrine, a Natural Inhibitor of Candida albicans Drug Efflux Pumps
Zhang, H., Gao, A., Li, F., Zhang, G., Hon In, H. O., & Liao, W. (2009) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.129.623 · Cited by 49
Fluconazole Treatment Is Effective against a Candida albicans erg3/erg3 Mutant In Vivo Despite In Vitro Resistance
Miyazaki, T., Miyazaki, Y., Izumikawa, K., Kakeya, H., Miyakoshi, S., Bennett, J. E., & Kohno, S. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.580-586.2006 · Cited by 48
Broad-spectrum antifungal activity of spirooxindolo-pyrrolidine tethered indole/imidazole hybrid heterocycles against fungal pathogens
Bolous, M., Arumugam, N., Almansour, A. I., Kumar, R. S., Maruoka, K., Antharam, V. C., & Thangamani, S. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.07.022 · Cited by 48
Potential role of aerosolized amphotericin B formulations in the prevention and adjunctive treatment of invasive fungal infections
Drew, R. H. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.03.018 · Cited by 48
In vitroandin vivointeractions between fluconazole and allicin against clinical isolates of fluconazole-resistantCandida albicansdetermined by alternative methods
Guo, N., Wu, X., Yu, L., Liu, J., Meng, R., Jin, J., Lu, H., Wang, X., Yan, S., & Deng, X. (2009) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2009.00620.x · Cited by 49
Involvement of PDK1, PKC and TOR signalling pathways in basal fluconazole tolerance in Cryptococcus neoformans
Lee, H., Lamichhane, A. K., Garraffo, H. M., Kwon-Chung, K. J., & Chang, Y. C. (2012) · Molecular Microbiology · doi:10.1111/j.1365-2958.2012.08016.x · Cited by 50
Response of sessile cells to stress: from changes in gene expression to phenotypic adaptation
Coenye, T. (2010) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2010.00682.x · Cited by 53
Antifungal susceptibility ofMalassezia pachydermatisbiofilm
Figueredo, L. A., Cafarchia, C., & Otranto, D. (2013) · Medical Mycology · doi:10.3109/13693786.2013.805440 · Cited by 46
Morphogenic regulator EFG1 affects the drug susceptibilities of pathogenic Candida albicans: EFG1 regulates multidrug resistance in Candida albicans
Prasad, T., Hameed, S., Manoharlal, R., Biswas, S., Mukhopadhyay, C. K., Goswami, S. K., & Prasad, R. (2010) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2010.00639.x · Cited by 46
Emerging fungal resistance
Baddley, J. W., & Moser, S. A. (2004) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2004.05.003 · Cited by 47
Uptake of T-2307, a novel arylamidine, in Candida albicans
Nishikawa, H., Yamada, E., Shibata, T., Uchihashi, S., Fan, H., Hayakawa, H., Nomura, N., & Mitsuyama, J. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq177 · Cited by 46
A Phase 2, Open-Label Study of the Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis
Vázquez, J. A., Schranz, J., Clark, K., Goldstein, B. P., Reboli, A. C., & Fichtenbaum, C. J. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31817af47a · Cited by 45
In vitro antifungal susceptibility of Candida spp. oral isolates from HIV-positive patients and control individuals
Back‐Brito, G. N., Inocêncio, A. C., Querido, S. M. R., Jorge, A. O. C., & Koga‐Ito, C. Y. (2011) · Brazilian Oral Research · doi:10.1590/s1806-83242011005000001 · Cited by 45
Mechanisms of resistance to fluconazole in Candida albicans clinical isolates from Iranian HIV-infected patients with oropharyngeal candidiasis
Salari, S., Khosravi, A., Mousavi, S. A. A., & Nikbakht-Brojeni, G. H. (2015) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2015.10.007 · Cited by 45
Antifungal activity and influence of propolis against germ tube formation as a critical virulence attribute by clinical isolates of Candida albicans
Haghdoost, N. S., Salehi, T. Z., Khosravi, A., & Sharifzadeh, A. (2016) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2015.11.004 · Cited by 45
Mutations and/or Overexpressions of ERG4 and ERG11 Genes in Clinical Azoles-Resistant Isolates of Candida albicans
Feng, W., Yang, H. J., Xi, Z., Qiao, Z., Lv, Y., Wang, Y., Ma, Y., Wang, Y., & Wen, C. (2016) · Microbial Drug Resistance · doi:10.1089/mdr.2016.0095 · Cited by 45
Molecular Mechanism of Drug Resistance
Ray, S., Das, S., & Suar, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-48683-3_3 · Cited by 51
Structure and Biological Activities of β‐Glucans from Yeast and Mycelial Forms of Candida albicans
Miura, N. N., Adachi, Y., Yadomae, T., Tamura, H., Tanaka, S., & Ohno, N. (2003) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2003.tb03382.x · Cited by 45
Inhibition of Candida albicans virulence factors by novel levofloxacin derivatives
Shafreen, R. B., Muthamil, S., & Pandian, S. K. (2014) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-014-5719-2 · Cited by 42
Emerging Mechanisms of Drug Resistance in Candida albicans
Prasad, R., Nair, R., & Banerjee, A. (2019) · Progress in molecular and subcellular biology · doi:10.1007/978-3-030-13035-0_6 · Cited by 44
Clotrimazole for Vulvovaginal Candidosis: More Than 45 Years of Clinical Experience
Mendling, W., Shazly, M. A. E., & Zhang, L. (2020) · Pharmaceuticals · doi:10.3390/ph13100274 · Cited by 43
The RTA3 Gene, Encoding a Putative Lipid Translocase, Influences the Susceptibility of Candida albicans to Fluconazole
Whaley, S. G., Tsao, S., Weber, S., Zhang, Q., Barker, K. S., Raymond, M., & Rogers, P. D. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00732-16 · Cited by 41
Synthesis, characterization, and application of a novel water-soluble polyethyleneimine-based Schiff base colorimetric chemosensor for metal cations and biological activity
Yıldız, M., Demir, N., Ünver, H., & Şahiner, N. (2017) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2017.05.159 · Cited by 41
RTA2, a novel gene involved in azole resistance in Candida albicans
Jia, X., Ma, Z., Jia, Y., Gao, P., Zhang, J., Wang, Y., Yong-gang, X., Wang, L., Cao, Y., Cao, Y., et al. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.06.093 · Cited by 40
Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India
Mane, A. K., Vidhate, P., Kusro, C., Waman, V., Saxena, V., Kulkarni‐Kale, U., & Risbud, A. (2015) · Mycoses · doi:10.1111/myc.12439 · Cited by 41
Yeast Colonization and Drug Susceptibility Pattern in the Pediatric Patients With Neutropenia
Haddadi, P., Zareifar, S., Badiee, P., Alborzi, A., Mokhtari, M., Zomorodian, K., Pakshir, K., & Jafarian, H. (1970) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.11858 · Cited by 40
Synthesis, spectral and quantum chemical studies and use of ( E )-3-[(3,5-bis(trifluoromethyl)phenylimino)methyl]benzene-1,2-diol and its Ni(II) and Cu(II) complexes as an anion sensor, DNA binding, DNA cleavage, anti-microbial, anti-mutagenic and anti-cancer agent
Ünver, H., Boyacıoğlu, B., Zeyrek, C. T., Yıldız, M., Demir, N., YILDIRIM, N., Karaosmanoğlu, O., Sivas, H., & Elmalı, A. (2016) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2016.06.058 · Cited by 40
The synergy of honokiol and fluconazole against clinical isolates of azole-resistant Candida albicans: Synergy of HNK and FLC on Candida
Jin, J., Guo, N., Zhang, J., Ding, Y., Tang, X., Liang, J., Li, L., Deng, X., & Yu, L. (2010) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.2010.02900.x · Cited by 40
Synthesis and chain-dependent antifungal activity of long-chain 2H-azirine-carboxylate esters related to dysidazirine
Skepper, C. K., Dalisay, D. S., & Molinski, T. F. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.01.068 · Cited by 40
Cross-Resistance to Medical and Agricultural Azole Drugs in Yeasts from the Oropharynx of Human Immunodeficiency Virus Patients and from Environmental Bavarian Vine Grapes
Müller, F. C., Staudigel, A., Salvenmoser, S., Tredup, A., Miltenberger, R., & Herrmann, J. V. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00459-07 · Cited by 40
In vitro photodynamic inactivation of Candida albicans by phenothiazine dye (new methylene blue) and Indocyanine green (EmunDo®)
Fekrazad, R., Barghi, V. G., Mir, A. P. B., & Shams‐Ghahfarokhi, M. (2015) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2014.12.006 · Cited by 39
Conventional and alternative antifungal therapies to oral candidiasis
Aníbal, P. C., Sardi, J. D. C. O., Peixoto, I. T. A., Moraes, J. J. D. C., & Höfling, J. F. (2010) · Brazilian Journal of Microbiology · doi:10.1590/s1517-83822010000400001 · Cited by 39
Cross‐resistance to fluconazole induced by exposure to the agricultural azole tetraconazole: an environmental resistance school?
Rocha, M. F. G., de Alencar, L. P., Paiva, M. A. N., Melo, L. M., Bandeira, S. P., de Ponte, Y. B., Sales, J. A., Guedes, G. M. D. M., Castelo‐Branco, D. D. S. C. M., Bandeira, T. J. P. G., et al. (2016) · Mycoses · doi:10.1111/myc.12457 · Cited by 38
Mutational Analysis of Intracellular Loops Identify Cross Talk with Nucleotide Binding Domains of Yeast ABC Transporter Cdr1p
Shah, A. H., Rawal, M. K., Dhamgaye, S., Komath, S. S., Saxena, A. K., & Prasad, R. (2015) · Scientific Reports · doi:10.1038/srep11211 · Cited by 38
Antifungal activity and cytotoxicity of extracts and triterpenoid saponins obtained from the aerial parts of Anagallis arvensis L.
Soberón, J. R., Sgariglia, M. A., Pastoriza, A. C., Soruco, E. M., Jäger, S. N., Labadié, G. R., Sampietro, D. A., & Vattuone, M. A. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.03.056 · Cited by 36
Benzimidazole tethered pyrrolo[3,4-b]quinoline with broad-spectrum activity against fungal pathogens
Villa, P., Arumugam, N., Almansour, A. I., Kumar, R. S., Mahalingam, S. M., Maruoka, K., & Thangamani, S. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.01.006 · Cited by 37
The Effect of Complete Dentures with a Metal Palate on Candida Species Growth in HIV‐Infected Patients
Perezous, L. F., Stevenson, G. C., Flaitz, C. M., Goldschmidt, M. E., Engelmeier, R. L., & Nichols, C. M. (2006) · Journal of Prosthodontics · doi:10.1111/j.1532-849x.2006.00127.x · Cited by 37
Disruption of the Transcriptional Regulator Cas5 Results in Enhanced Killing of Candida albicans by Fluconazole
Vasicek, E. M., Berkow, E. L., Bruno, V. M., Mitchell, A. P., Wiederhold, N. P., Barker, K. S., & Rogers, P. D. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00064-14 · Cited by 38
The drug transporter MgMfs1 can modulate sensitivity of field strains of the fungal wheat pathogen Mycosphaerella graminicola to the strobilurin fungicide trifloxystrobin
Roohparvar, R., Mehrabi, R., van Nistelrooy, J. G. M., Zwiers, L. H., & Waard, M. A. D. (2008) · Pest Management Science · doi:10.1002/ps.1569 · Cited by 37
In Vitro Fluconazole Susceptibility of 1,903 Clinical Isolates of Candida albicans and the Identification of ERG11 Mutations
Ying, Y., Zhao, Y., Hu, X., Cai, Z., Liu, X., Jin, G., Zhang, J., Zhang, J., Liu, J., & Huang, X. (2013) · Microbial Drug Resistance · doi:10.1089/mdr.2012.0204 · Cited by 36
Calcineurin Promotes Infection of the Cornea by Candida albicans and Can Be Targeted To Enhance Fluconazole Therapy
Onyewu, C., Afshari, N. A., & Heitman, J. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00393-06 · Cited by 36
In VitroEffect of Malachite Green on Candida albicans Involves Multiple Pathways and Transcriptional RegulatorsUPC2andSTP2
Dhamgaye, S., Devaux, F., Manoharlal, R., Vandeputte, P., Shah, A. H., Singh, A., Blugeon, C., Sanglard, D., & Prasad, R. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00574-11 · Cited by 35
ERG11 mutations and expression of resistance genes in fluconazole-resistant Candida albicans isolates
Xu, Y., Sheng, F., Zhao, J., Chen, L., & Li, C. (2015) · Archives of Microbiology · doi:10.1007/s00203-015-1146-8 · Cited by 37
In vitro photodynamic inactivation of Candida spp. by different doses of low power laser light
Queiroga, A. S., Trajano, V. N., Lima, E. O., Ferreira, A. F. M., Queiroga, A. S., & Limeira, F. (2011) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2011.08.005 · Cited by 35
Evolutionary Dynamics of Candida albicans during In Vitro Evolution
Huang, M., McClellan, M., Berman, J., & Kao, K. C. (2011) · Eukaryotic Cell · doi:10.1128/ec.05168-11 · Cited by 34
Amino Acid Substitutions at the Major Insertion Loop of Candida albicans Sterol 14alpha-Demethylase Are Involved in Fluconazole Resistance
Alvarez-Rueda, N., Fleury, A., Morio, F., Pagniez, F., Gastinel, L. N., & Pape, P. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021239 · Cited by 33
Antifungal Synergy of Theaflavin and Epicatechin Combinations Against Candida albicans
Betts, J. W. (2013) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1303.03010 · Cited by 34
Pleiotropic effects of the vacuolar ABC transporter MLT1 of Candida albicans on cell function and virulence
Khandelwal, N., Kämmer, P., Förster, T. M., Singh, A., Coste, A. T., Andes, D. R., Hube, B., Sanglard, D., Chauhan, N., Kaur, R., et al. (2016) · Biochemical Journal · doi:10.1042/bcj20160024 · Cited by 34
The Synergism of the Small Molecule ENOblock and Fluconazole Against Fluconazole-Resistant Candida albicans
Li, L., Zhang, T., Xu, J., Wu, J., Wang, Y., Qiu, X.-R., Zhang, Y., Hou, W.-T., Yan, L., An, M., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02071 · Cited by 34
T-2307, a novel arylamidine, is transported into Candida albicans by a high-affinity spermine and spermidine carrier regulated by Agp2
Nishikawa, H., Sakagami, T., Yamada, E., Fukuda, Y., Hayakawa, H., Nomura, N., Mitsuyama, J., Miyazaki, T., Mukae, H., & Kohno, S. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw095 · Cited by 34
Overexpression and mutation as a genetic mechanism of fluconazole resistance in Candida albicans isolated from human immunodeficiency virus patients in Indonesia
Rosana, Y., Yasmon, A., & Lestari, D. C. (2015) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000123 · Cited by 33
Evaluation of the Antifungal and Wound-Healing Properties of a Novel Peptide-Based Bioadhesive Hydrogel Formulation
Sultan, A. S., Vila, T. V. M., Hefni, E., Karlsson, A. J., & Jabra‐Rizk, M. A. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00888-19 · Cited by 32
Synergistic antifungal effects of curcumin derivatives as fungal biofilm inhibitors with fluconazole
Dong, H., Wang, Y., Peng, X., Zhou, H., Zhao, F., Jiang, Y., Zhang, D., & Jin, Y. (2021) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13827 · Cited by 32
Dynamics ofin vitro acquisition of resistance byCandida parapsilosisto different azoles
Silva, A. P., Costa‐de‐Oliveira, S., Silva-Dias, A., Pina‐Vaz, C., & Rodrigues, A. G. (2009) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2009.00508.x · Cited by 35
The photodynamic activity of a novel porphyrin derivative bearing a fluconazole structure in different media and against Candida albicans
Mora, S. J., Cormick, M. P., Milanesio, M. E., & Durantini, E. N. (2010) · Dyes and Pigments · doi:10.1016/j.dyepig.2010.04.001 · Cited by 31

Authors: White, T. C., Holleman, S., Dy, F., Mirels, L. F., & Stevens, D. A.
Affiliations: Center for Infectious Disease Research (US)
Santa Clara Valley Medical Center (US)
Corresponding author: White, Theodore C.
ORCID: White, Theodore C.
Stevens, David A.
Venue: Antimicrobial Agents and Chemotherapy
Publisher: American Society for Microbiology
Published: 2002-06
Volume: 46
Issue: 6
Pages: 1704-1713
ISSN: 0066-4804 (ISSN-L)
1098-6596
DOI: 10.1128/aac.46.6.1704-1713.2002
PMC: PMC127245
OpenAlex: W2117461892
Cited by: 461
References: 42
Citations by year: 2026: 8 · 2025: 9 · 2024: 14 · 2023: 15 · 2022: 24 · 2021: 9 · 2020: 16 · 2019: 28 · 2018: 16 · 2017: 23 · 2016: 22 · 2015: 31 · 2014: 28 · 2013: 19 · 2012: 12
FWCI: 13.35
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: journals.asm.org/non-commercial-tdm-license (tdm)
Locations: Antimicrobial Agents and Chemotherapy (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Burroughs Wellcome Fund
M.J. Murdock Charitable Trust
National Institutes of Health
National Institute of Dental and Craniofacial Research (R01DE011367, R01 DE-11367)
Topics: Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
Keywords: Candida albicans, azole resistance, drug resistance mechanisms, ERG11 mutations, CDR1, CDR2, MDR1, efflux pump overexpression, cross-resistance, fluconazole, clotrimazole, itraconazole, ketoconazole, clinical isolates
MeSH terms: Antifungal Agents, Candida albicans, Candidiasis, DNA, Fungal, Drug Resistance, Microbial, Fungal Proteins, Microbial Sensitivity Tests, Phenotype, Polymorphism, Restriction Fragment Length, RNA, Fungal, Blotting, Southern, Blotting, Northern, DNA Probes, Gene Expression Regulation, Fungal, Drug Resistance, Multiple, ATP-Binding Cassette Transporters, Genes, MDR, Reverse Transcriptase Polymerase Chain Reaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Resistance Mechanisms in Clinical Isolates of Candida albicans

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks